Award description
AIDS MALIGNANCY CONSORTIUM (AMC)
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
The Buildout's read
What the model surfaced from this award
Confidence: high
In plain English
Funds the AIDS Malignancy Consortium to research and treat cancers in HIV-positive patients.
Sub-sectors
hiv-aids-researchcancer-oncologyclinical-consortia
Why this matters
Addresses critical health disparities in HIV populations; advances understanding of cancer pathogenesis in immunocompromised patients.
Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-14. Cost: $0.001148.
Period of performance
Start
2006-03-01
End
2025-08-31
Status
expired257 days ago
Sources
- Award record ingested from usaspending. Source identifier ASST_NON_UM1CA121947_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.